354 related articles for article (PubMed ID: 8256456)
1. Anabolic steroids in corticosteroid-induced osteoporosis.
Adami S; Rossini M
Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
[TBL] [Abstract][Full Text] [Related]
2. Anabolic steroids in postmenopausal osteoporosis.
Need AG; Durbridge TC; Nordin BE
Wien Med Wochenschr; 1993; 143(14-15):392-5. PubMed ID: 8256455
[TBL] [Abstract][Full Text] [Related]
3. [Effect of anabolic steroids on osteoporosis].
Adachi M; Takayanagi R
Clin Calcium; 2008 Oct; 18(10):1451-9. PubMed ID: 18830042
[TBL] [Abstract][Full Text] [Related]
4. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
Need AG; Horowitz M; Bridges A; Morris HA; Nordin BE
Arch Intern Med; 1989 Jan; 149(1):57-60. PubMed ID: 2912415
[TBL] [Abstract][Full Text] [Related]
5. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE
Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
[TBL] [Abstract][Full Text] [Related]
6. The action of anabolic steroids on bone in experimental animals.
Schot LP; Schuurs AH; Kloosterboer HJ
Wien Med Wochenschr; 1993; 143(14-15):385-7. PubMed ID: 8256453
[TBL] [Abstract][Full Text] [Related]
7. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
Tengstrand B; Cederholm T; Söderqvist A; Tidermark J
Clin Nutr; 2007 Aug; 26(4):460-5. PubMed ID: 17498850
[TBL] [Abstract][Full Text] [Related]
8. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.
Adami S; Fossaluzza V; Rossini M; Bertoldo F; Gatti D; Zamberlan N; Lo Cascio V
Bone Miner; 1991 Oct; 15(1):73-81. PubMed ID: 1747568
[TBL] [Abstract][Full Text] [Related]
9. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
Erdtsieck RJ; Pols HA; van Kuijk C; Birkenhäger-Frenkel DH; Zeelenberg J; Kooy PP; Mulder P; Birkenhäger JC
J Bone Miner Res; 1994 Feb; 9(2):277-83. PubMed ID: 8140941
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, biochemistry and some results with treatment of postmenopausal osteoporosis.
Hassager C; Christiansen C
Wien Med Wochenschr; 1993; 143(14-15):389-91. PubMed ID: 8256454
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcitonin or the anabolic steroid Decadurabolin on serum beta 2 microglobulin in osteoporotic postmenopausal women.
Cantatore FP; Loperfido MC; Mancini L; Carrozzo M
J Rheumatol; 1992 Nov; 19(11):1753-5. PubMed ID: 1491396
[TBL] [Abstract][Full Text] [Related]
12. Effects of nandrolone decanoate on bone mass in established osteoporosis.
Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
14. [Estrogens, anabolic steroids and postmenopausal osteoporosis: what are the facts?].
Birkenhäger JC
Ned Tijdschr Geneeskd; 1991 Jun; 135(22):973-5. PubMed ID: 2062392
[No Abstract] [Full Text] [Related]
15. [Steroid osteoporosis].
Kocián J
Vnitr Lek; 1998 Feb; 44(2):86-92. PubMed ID: 9820082
[TBL] [Abstract][Full Text] [Related]
16. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Gennari C; AgnusDei D; Gonnelli S; Nardi P
Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.
Bolanca S; Korsić M; Dekanić D; Cvijetić S
Acta Med Croatica; 1998; 52(3):159-63. PubMed ID: 9818438
[TBL] [Abstract][Full Text] [Related]
18. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
Hassager C; Jensen LT; Pødenphant J; Thomsen K; Christiansen C
Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
20. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
